Reduced insulin signaling in the pancreas's digestive tissue in type 1 diabetes

Loss of insulin signaling across functional pancreas compartments as a major pathogenic mechanism underlying diabetic exocrine pancreatopathy

NIH-funded research University of Miami School of Medicine · NIH-11249532

Researchers want to learn if low insulin near the pancreas causes damage to the digestive part of the pancreas in adults with type 1 diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine NIH-funded
Lab location1 site (Coral Gables, United States)
Project IDNIH-11249532 on NIH RePORTER

What this research studies

If you have type 1 diabetes, this project looks at how losing insulin-producing beta cells changes the nearby digestive pancreas. The team will study human pancreas tissue and run lab experiments to see how insulin acts on acinar cells, the small blood-vessel units (pericytes and endothelial cells), and local pancreatic nerves. They will compare samples from adults with type 1 diabetes to healthy tissue and use molecular tests and imaging to track fibrosis, fat changes, inflammation, and vessel abnormalities. The researchers aim to map how loss of local insulin leads to the specific pancreatic damage called diabetic exocrine pancreatopathy.

Who could benefit from this research

Good fit: Adults with type 1 diabetes, especially those showing signs of pancreatic exocrine dysfunction or related digestive problems, would be the most relevant participants.

Not a fit: People without type 1 diabetes or whose pancreatic disease is due to other causes (for example classic chronic pancreatitis) are unlikely to benefit directly from this work.

Why it matters

Potential benefit: If successful, this work could point to ways to prevent or treat digestive pancreas damage and related complications in people with type 1 diabetes.

How similar studies have performed: Previous studies have documented exocrine pancreas changes in type 1 diabetes and early lab work supports local insulin effects, but tying together acinar cells, microvasculature, and nerves as a single mechanism is a relatively new approach.

Where this research is happening

Coral Gables, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Atherosclerotic Cardiovascular Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.